These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35557495)

  • 21. Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization.
    Bengtson LGS; Yu Y; Wang W; Cao F; Hulbert EM; Wolbeck R; Elliott CA; Buikema AR
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1149-1159. PubMed ID: 29083972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients' experiences of asthma exacerbation and management: a qualitative study of severe asthma.
    Song WJ; Won HK; Lee SY; Park HK; Cho YS; Chung KF; Heaney LG; Joung WJ
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 33834052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma.
    Heatley H; Tran TN; Bourdin A; Menzies-Gow A; Jackson DJ; Maslova E; Chapaneri J; Skinner D; Carter V; Chan JSK; Ariti C; Haughney J; Price DB
    Thorax; 2023 Sep; 78(9):860-867. PubMed ID: 36575040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden.
    Ekström M; Nwaru BI; Hasvold P; Wiklund F; Telg G; Janson C
    Allergy; 2019 Nov; 74(11):2181-2190. PubMed ID: 31095758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
    Anderson DE; Kew KM; Boyter AC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma.
    Eger K; Amelink M; Hashimoto S; Hekking PP; Longo C; Bel EH
    Respiration; 2022; 101(2):116-121. PubMed ID: 34535586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR).
    Janson C; Lisspers K; Ställberg B; Johansson G; Telg G; Thuresson M; Nordahl Christensen H; Larsson K
    Respir Res; 2018 Sep; 19(1):168. PubMed ID: 30176850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma.
    Al Efraij K; Johnson KM; Wiebe D; Sadatsafavi M; FitzGerald JM
    J Asthma; 2019 Dec; 56(12):1334-1346. PubMed ID: 30513226
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in oral corticosteroid use in asthma treatment-A 20-year Danish nationwide drug utilisation study.
    Skov IR; Henriksen DP; Madsen H; Pottegård A; Davidsen JR
    Basic Clin Pharmacol Toxicol; 2022 Jan; 130(1):122-131. PubMed ID: 34709724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry.
    Thomas D; Harvey ES; McDonald VM; Stevens S; Upham JW; Katelaris CH; Kritikos V; Gillman A; Harrington J; Hew M; Bardin P; Peters M; Reynolds PN; Langton D; Baraket M; Bowden JJ; Bowler S; Chien J; Chung LP; Farah CS; Grainge C; Jenkins C; Katsoulotos GP; Lee J; Radhakrishna N; Reddel HK; Rimmer J; Sivakumaran P; Wark PAB; Gibson PG
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2715-2724.e5. PubMed ID: 33545399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand.
    Blakey J; Chung LP; McDonald VM; Ruane L; Gornall J; Barton C; Bosnic-Anticevich S; Harrington J; Hew M; Holland AE; Hopkins T; Jayaram L; Reddel H; Upham JW; Gibson PG; Bardin P
    Respirology; 2021 Dec; 26(12):1112-1130. PubMed ID: 34587348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma.
    Ververeli K; Chipps B
    Ann Allergy Asthma Immunol; 2004 May; 92(5):512-22. PubMed ID: 15191019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Characteristics and Disease Burden of Severe Asthma According to Oral Corticosteroid Dependence: Real-World Assessment From the Korean Severe Asthma Registry (KoSAR).
    Lee JH; Kim HJ; Park CS; Park SY; Park SY; Lee H; Kim SH; Cho YS;
    Allergy Asthma Immunol Res; 2022 Jul; 14(4):412-423. PubMed ID: 35837824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality.
    Skov IR; Madsen H; Henriksen DP; Andersen JH; Pottegård A; Davidsen JR
    Eur Respir J; 2022 Sep; 60(3):. PubMed ID: 35144997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care.
    Murray CS; Lucas SJ; Blakey J; Kaplan A; Papi A; Paton J; Phipatanakul W; Price D; Teoh OH; Thomas M; Turner S; Papadopoulos NG
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33419889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
    McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
    Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unmet Need for Oral Corticosteroids Use and Exacerbations of Asthma in Primary Care in Taiwan.
    Chen YW; Hsiao YH; Ko HK; Jeng TH; Su KC; Perng DW
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36552009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practice patterns for oral corticosteroid burst therapy in the outpatient management of acute asthma exacerbations.
    Fuhlbrigge AL; Lemanske RF; Rasouliyan L; Sorkness CA; Fish JE
    Allergy Asthma Proc; 2012; 33(1):82-9. PubMed ID: 22183118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of omalizumab in severe allergic asthma: a retrospective UK real-world study.
    Barnes N; Menzies-Gow A; Mansur AH; Spencer D; Percival F; Radwan A; Niven R
    J Asthma; 2013 Jun; 50(5):529-36. PubMed ID: 23574000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticosteroid choice and clinical outcomes for asthma exacerbations in the primary care setting.
    Navanandan N; Moss A; Tanverdi M; Ambroggio L; Brittan M
    J Asthma; 2022 Feb; 59(2):333-341. PubMed ID: 33106059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.